Report Categories Report Categories

Report Categories

industry Category

All

Total: 2 records, 1 pages

Global Autologous CAR-T Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 06 Sep 2024

date Medical Care

new_biaoQian Autologous CAR-T Cell Therapy

CAR-T cell therapy is a novel immunotherapy method, abbreviated as chimeric antigen receptor T cells. Autologous CAR-T cell therapy uses the patient's own T cells, which are genetically engineered to express a specific receptor, thereby enhancing their ability to target tumor cells.

USD3480.00

Add To Cart

Add To Cart

Global Autologous CAR-T Cell Therapy Supply, Demand and Key Producers, 2024-2030

date 06 Sep 2024

date Medical Care

new_biaoQian Autologous CAR-T Cell Therapy

CAR-T cell therapy is a novel immunotherapy method, abbreviated as chimeric antigen receptor T cells. Autologous CAR-T cell therapy uses the patient's own T cells, which are genetically engineered to express a specific receptor, thereby enhancing their ability to target tumor cells.

USD4480.00

Add To Cart

Add To Cart

industry 06 Sep 2024

industry Medical Care

new_biaoQian Autologous CAR-T Cell Therapy

CAR-T cell therapy is a novel immunotherapy method, abbreviated as chimeric antigen receptor T cells. Autologous CAR-T cell therapy uses the patient's own T cells, which are genetically engineered to express a specific receptor, thereby enhancing their ability to target tumor cells.

USD3480.00

addToCart

Add To Cart

industry 06 Sep 2024

industry Medical Care

new_biaoQian Autologous CAR-T Cell Therapy

CAR-T cell therapy is a novel immunotherapy method, abbreviated as chimeric antigen receptor T cells. Autologous CAR-T cell therapy uses the patient's own T cells, which are genetically engineered to express a specific receptor, thereby enhancing their ability to target tumor cells.

USD4480.00

addToCart

Add To Cart